Document is current
Any future updates will be listed below
-
Authors
Sadeghi, Mahvash
Dehnavi, Sajad
Khodadadi, Ali
Ghadiri, Ata. A.
Ganji, Ali
Sharifat, Moosa
Asadirad, Ali
-
Funding
Funding for this research was provided by:
Ahvaz Jundishapur University of Medical Sciences (CMRC-9924)
- License Information
-
More Information
Article History
Received: 30 September 2024
Accepted: 6 December 2024
First Online: 18 December 2024
Declarations
:
: This study is based on the approved project entitled “Evaluation the efficacy of sublingually administrated OVA-encapsulated Adipose-derived mesenchymal stem cell-derived exosome nanoparticles modified by DC-specific aptamer in allergic mouse model”. All experiments were approved by the Institutional Animal Ethics Committee of the Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (Approval number: IR.AJUMS.ABHC.REC.1399.059) (Date of approval: 2021.1.12). In addition, this work has been reported in line with the ARRIVE guidelines 2.0.
: All authors declare no potential conflict of interest.
: The authors declare that they have not use AI-generated work in this manuscript.
